martes, 6 de octubre de 2026
BuscarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· April 10, 2026

Robust Trading, IB Fee Growth to Support Morgan Stanley's Q1 Earnings

View original at finance.yahoo.com
Robust Trading, IB Fee Growth to Support Morgan Stanley's Q1 Earnings Morgan Stanley MS is slated to announce first-quarter 2026 earnings on April 15 before the opening bell…
Opening lines of the source · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Fixed-income underwriting fees are estimated at $667.3 million, indicating a 1.4% fall

    60% confidence
  • Management expects net interest income in the wealth management segment to rise modestly on a sequential basis

    60% confidence
  • Investment banking income is expected to reach $2.02 billion, indicating a 29.5% year-over-year jump

    60% confidence
  • Morgan Stanley's Q1 2026 earnings are estimated at $3.08 per share, indicating an 18.5% increase from the prior-year quarter

    60% confidence
  • Fixed-income trading revenues are estimated at $2.9 billion, indicating an 11.2% gain

    60% confidence
  • Morgan Stanley's earnings outpaced the Zacks Consensus Estimate in each of the trailing four quarters, with the average beat being 18.19%

    60% confidence
  • Morgan Stanley's first-quarter revenues are expected to reach $19.88 billion, suggesting 12.1% year-over-year growth

    60% confidence
  • Total underwriting fees are estimated at $1.06 billion, implying a 6.7% rise

    60% confidence
  • Advisory fees are expected to be $883.7 million, indicating a 51.6% year-over-year jump

    60% confidence
  • Equity trading revenues are estimated at $4.74 billion, suggesting a 15% rise from the prior-year quarter

    60% confidence
  • Companies acknowledged that volatility is part of life and they will have to do business around it, unlike last year when tariff announcements led to deal drought

    60% confidence
  • Net interest revenues are estimated at $2.58 billion, suggesting a 9.7% year-over-year rise

    60% confidence
  • Equity underwriting fees are estimated at $395.2 million, suggesting 23.9% year-over-year growth

    60% confidence
Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Nuestra lectura de los datos ›
Señales que seguimos
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patrones que observamos ›
Donde las fuentes discrepan
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,985
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,985 hechos verificados con la fuente5,351 documentos fuente archivados
Consulta estos datos → isubstrate.com
Robust Trading, IB Fee Growth to Support Morgan Stanley's Q1 Earnings — Source | Via News | es.VIA.NEWS